Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Anthera Pharmaceuticals, Inc.
Type
Public
Traded as NASDAQ: ANTH
Industry Pharmaceuticals
Founded 2004
Headquarters Hayward, California, U.S.
Key people
Craig Thompson
(President and CEO)
Website Anthera.com

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera’s leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.

July 2014, Anthera acquired Sollpura (Liprotamase) from Eli Lilly and Company. Sollpura is an investigational pancreatic enzyme replacement therapy (PERT) that uses three biotechnology-derived digestive enzymes intended to treat patients with endocrine pancreatic insufficiency as a result of cystic fibrosis and other diseases.

Investment goal date:
Dividends reinvested
Anthera Pharmaceuticals, Inc. ANTH report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-10
--
--
Q4 2017
2018-03-09
--
--
Q4 2017
2018-02-26
--
--
Q3 2017
2017-11-06
--
--
Q3 2017
2017-11-06
-0.5800
-0.5800
Q2 2017
2017-08-09
0.0300
0.0300
Q1 2017
2017-05-10
-2.0300
-2.0000
Q4 2016
2017-02-27
-3.2000
-2.8800
Q3 2016
2016-11-04
-4.8800
-4.8800
Q2 2016
2016-08-09
-2.8000
-2.8000
Q1 2016
2016-05-09
-2.3200
-2.3200
Q4 2015
2016-03-10
-1.4400
-1.4400
Q3 2015
2015-11-06
-2.3200
-2.3200
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
1263899
BlackRock Inc.
2897479
BlackRock Institutional Trust Company, N.A.
866924
BVF INC/IL
8052073
DEUTSCHE BANK AG\
947187
FRANKLIN RESOURCES INC
3197712
GEODE CAPITAL MANAGEMENT, LLC
355172
GOLDMAN SACHS GROUP INC
359982
NORTHERN TRUST CORP
419722
Rock Springs Capital Management LP
1296568
SABBY MANAGEMENT, LLC
1757697
Sio Capital Management, LLC
333712
STATE STREET CORP
678489
UBS Group AG
375989
Vanguard Group, Inc
2691639
Major Shareholders
Name Relationship
Total Shares
Holding stocks
ORBIMED ADVISORS LLC
32.8500% (7462000)
TRUEX PAUL F
0.0700% (16793)
ANTH / CBAY /
SOFINNOVA VENTURE PARTNERS VI L P
0.2000% (44969)
ANTH / OCRX /
HENNEY CHRISTOPHER S
0.4400% (100000)
ANTH / CYCC / ONTY / PRTA /
HEALY JAMES
0.1400% (32443)
DZIURZYNSKI BOGDAN
0.0400% (10000)
ANTH / DNDN /
VANTAGEPOINT VENTURE ASSOCIATES IV LLC
23.5900% (5357528)
ANTH / GCAP / WAGE /
ODINK DEBRA
0.0300% (7896)
ANTH /
KILFOIL GEORGINA
0.1300% (30035)
ANTH /
Hislop Colin
0.1400% (31647)
ANTH / VSAR /
LOWE CHRISTOPHER P.
0.4800% (108915)
ANTH / HNSN /
Thompson David E.
0.5600% (128201)
ANTH /
THOMPSON JOHN CRAIG
0.0900% (19848)
ANTH / TTPH /
Mueller Brian
0.0400% (10000)
ANTH / BMRN /
% ()